tiprankstipranks
Spruce Biosciences (SPRB)
NASDAQ:SPRB
US Market

Spruce Biosciences (SPRB) Financial Statements

Compare
296 Followers

Spruce Biosciences Financial Overview

Spruce Biosciences's market cap is currently $16.07M. The company's EPS TTM is $-0.958; its P/E ratio is ―; Spruce Biosciences is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 10.09M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -39.34M$ -429.00K$ -381.00K$ -102.00K$ -12.00K
Operating Income$ -51.99M$ -47.28M$ -42.07M$ -29.42M$ -13.11M
EBITDA$ -47.37M$ -45.33M$ -41.57M$ -29.11M$ -13.10M
Net Income$ -47.92M$ -45.08M$ -42.69M$ -30.03M$ -13.24M
Balance Sheet
Cash & Short-Term Investments$ 96.34M$ 79.08M$ 88.97M$ 157.15M$ 3.92M
Total Assets$ 103.95M$ 85.65M$ 126.49M$ 162.88M$ 4.69M
Total Debt$ 4.61M$ 6.18M$ 6.17M$ 6.13M$ 4.45M
Net Debt$ -91.73M$ -18.31M$ -36.58M$ -151.02M$ 521.00K
Total Liabilities$ 27.44M$ 17.16M$ 15.12M$ 13.46M$ 35.33M
Stockholders' Equity$ 76.51M$ 68.49M$ 111.37M$ 149.43M$ -30.64M
Cash Flow
Free Cash Flow$ -33.28M$ -41.69M$ -35.97M$ -27.59M$ -12.62M
Operating Cash Flow$ -33.27M$ -41.68M$ -35.88M$ -27.52M$ -12.62M
Investing Cash Flow$ 55.78M$ 23.69M$ -79.17M$ -74.00K$ -4.00K
Financing Cash Flow$ 49.14M$ -241.00K$ 643.00K$ 181.03M$ 12.43M
Currency in USD

Spruce Biosciences Earnings and Revenue History

Spruce Biosciences Debt to Assets

Spruce Biosciences Cash Flow

Spruce Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis